Point72 Asset Management Reports 1.4% Passive Stake in Cybin Inc. (CYBN) via Warrants and Common Shares

On May 15, 2026, Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen filed a Schedule 13G/A with the SEC, reporting a 1.4% ownership stake in Cybin Inc. (CYBN). The filing indicates that the reporting persons collectively beneficially own 686,669 common shares as of March 31, 2026. This total includes 666,985 common shares issuable upon the exercise of warrants held by an investment fund managed by Point72 Asset Management. Steven A. Cohen, as the controlling figure of both Point72 Asset Management and Point72 Capital Advisors, is deemed to have shared voting and dispositive power over these securities. This filing represents an increase from a previously reported 0.0% ownership level, though the reporting persons now hold less than 5% of the outstanding shares. The investment is described as passive, with no intent to influence or change the control of the issuer. Cybin Inc. is a biopharmaceutical company headquartered in Toronto, Ontario.